article thumbnail

Modernizing Pharmacovigilance Outsourcing

XTalks

Reduce Costs – With greater automation and easier upgrades to new software releases to meet new and changing regulations, PV teams can reduce cost and risk and have more time to focus on high-value services.

article thumbnail

Private equity firms play ‘pass the Parexel’ with $8.5bn handover deal

pharmaphorum

Parexel has been a champion of the concept for years, but while adoption was fairly slow pre-COVID, it has accelerated at a fast pace since the crisis, aided by the increasing willingness of regulators to accept decentralised trial data in marketing applications.